Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Since 1996, the Food and Drug Administration (FDA) has received reports of more than 110 adverse events related to absorbable hemostatic agents, including 11 that resulted in paralysis or other neural deficits.

Hemostatic agent leads to 110 adverse events